Kazia Therapeutics Ltd (KZIA) is down Monday morning, with the stock declining -4.30% in pre-market trading to 1.78. KZIA's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 107 out of 146 industries, the stock ranks higher than 37% of stocks. Kazia Therapeutics Ltd has fallen 54.30% over the past month, closing at $3.97 on July 11. During this period of time, the stock fell as low as $1.76 and as high as $4.08. KZIA has an average analyst recommendation of Sell. The company has an average price target of $16.00.
Kazia Therapeutics Ltd has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, KZIA ranks better than 71% of stocks.
Should You Accumulate Kazia Therapeutics Ltd (KZIA) Stock Monday Morning?
KZIA has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on KZIA!